Ubs Group Ag Journey Medical Corp Transaction History

Ubs Group Ag

$555 Billion
Q2 2025

A detailed history of Ubs Group Ag transactions in Journey Medical Corp stock. As of the latest transaction made, Ubs Group Ag holds 158,751 shares of DERM stock, worth $1.15 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

158,751

Previous 17,038 831.75%

Holding current value

$1.15 Million

Previous $100,000 1039.0%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$5.97 - $8.07 $846,026 - $1.14 Million	141,713 Added 831.75%	158,751 $1.14 Million
Q1 2025 May 13, 2025	SELL	$3.66 - $6.54 $19,489 - $34,825	-5,325 Reduced 23.81%	17,038 $100,000
Q4 2024 Feb 14, 2025	BUY	$3.97 - $6.53 $88,781 - $146,030	22,363 New	22,363 $90,000
Q4 2023 Feb 09, 2024	BUY	$2.7 - $7.96 $32,186 - $94,891	11,921 Added 819.31%	13,376 $77,000
Q3 2023 Nov 09, 2023	SELL	$1.66 - $2.97 $697 - $1,247	-420 Reduced 22.4%	1,455 $3,000
Q2 2023 Aug 11, 2023	SELL	$1.03 - $2.26 $2,392 - $5,249	-2,323 Reduced 55.34%	1,875 $2,000
Q1 2023 May 12, 2023	BUY	$1.28 - $2.54 $5,373 - $10,662	4,198 New	4,198 $6,000
Q3 2022 Nov 10, 2022	SELL	$2.46 - $4.15 $3,062 - $5,166	-1,245 Reduced 46.3%	1,444 $4,000
Q2 2022 Aug 10, 2022	SELL	$2.62 - $5.06 $1,270 - $2,454	-485 Reduced 15.28%	2,689 $10,000
Q1 2022 May 16, 2022	SELL	$3.93 - $5.76 $290 - $426	-74 Reduced 2.28%	3,174 $15,000
Q4 2021 Feb 14, 2022	BUY	$5.17 - $9.9 $16,792 - $32,155	3,248 New	3,248 $17,000

Others Institutions Holding DERM

# of Institutions

Shares Held

Call Options Held

Put Options Held

View Full List

About Journey Medical Corp

Ticker DERM
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 11,596,500
Market Cap $84.2M
Description
Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat...

More about DERM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account